286 related articles for article (PubMed ID: 33488632)
1. A Novel Subset of CD95
Johnson C; Drummer Iv C; Shan H; Shao Y; Sun Y; Lu Y; Saaoud F; Xu K; Nanayakkara G; Fang P; Bagi Z; Jiang X; Choi ET; Wang H; Yang X
Front Immunol; 2020; 11():619951. PubMed ID: 33488632
[TBL] [Abstract][Full Text] [Related]
2. Metabolically Healthy Obesity (MHO) vs. Metabolically Unhealthy Obesity (MUO) Phenotypes in PCOS: Association with Endocrine-Metabolic Profile, Adherence to the Mediterranean Diet, and Body Composition.
Barrea L; Muscogiuri G; Pugliese G; de Alteriis G; Colao A; Savastano S
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836180
[TBL] [Abstract][Full Text] [Related]
3. Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy.
Kawai S; Yamakage H; Kotani K; Noda M; Satoh-Asahara N; Hashimoto K
Endocr J; 2023 Dec; 70(12):1175-1186. PubMed ID: 37793817
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity.
Lonardo A; Mantovani A; Lugari S; Targher G
Ann Hepatol; 2020; 19(4):359-366. PubMed ID: 32349939
[TBL] [Abstract][Full Text] [Related]
5. Peripheral invariant natural killer T cell deficiency in metabolically unhealthy but normal weight versus metabolically healthy but obese individuals.
Wang XL; Chang XY; Tang XX; Chen ZG; Zhou T; Sun K
J Int Med Res; 2016 Dec; 44(6):1272-1282. PubMed ID: 28322093
[TBL] [Abstract][Full Text] [Related]
6. MHO or MUO? White adipose tissue remodeling.
Zhao JY; Zhou LJ; Ma KL; Hao R; Li M
Obes Rev; 2024 Apr; 25(4):e13691. PubMed ID: 38186200
[TBL] [Abstract][Full Text] [Related]
7. Comparison between metabolically healthy obesity and metabolically unhealthy obesity by different definitions among Mexican children.
Evia-Viscarra ML; Guardado-Mendoza R
J Pediatr Endocrinol Metab; 2020 Feb; 33(2):215-222. PubMed ID: 31834862
[TBL] [Abstract][Full Text] [Related]
8. Exploring Therapeutic Targets to Reverse or Prevent the Transition from Metabolically Healthy to Unhealthy Obesity.
Dagpo TD; Nolan CJ; Delghingaro-Augusto V
Cells; 2020 Jul; 9(7):. PubMed ID: 32630256
[TBL] [Abstract][Full Text] [Related]
9. Adherence to the Mediterranean diet as a possible additional tool to be used for screening the metabolically unhealthy obesity (MUO) phenotype.
Barrea L; Verde L; Simancas-Racines D; Zambrano AK; Frias-Toral E; Colao A; Savastano S; Muscogiuri G
J Transl Med; 2023 Sep; 21(1):675. PubMed ID: 37770999
[TBL] [Abstract][Full Text] [Related]
10. Metabolically Healthy Obesity Is Characterized by a Proinflammatory Phenotype of Circulating Monocyte Subsets.
Christou KA; Christou GA; Karamoutsios A; Vartholomatos G; Gartzonika K; Tsatsoulis A; Tigas S
Metab Syndr Relat Disord; 2019 Jun; 17(5):259-265. PubMed ID: 30864887
[No Abstract] [Full Text] [Related]
11. Inflammation biomarkers and inflammatory genes expression in metabolically healthy obese patients.
Spoto B; Di Betta E; Pizzini P; Lonardi S; Mallamaci F; Tripepi G; Kanbay M; Cancarini G; Zoccali C
Nutr Metab Cardiovasc Dis; 2023 Mar; 33(3):584-591. PubMed ID: 36642614
[TBL] [Abstract][Full Text] [Related]
12. Transition patterns of metabolism-weight phenotypes over time: A longitudinal study using the multistate Markov model in China.
Zhang H; Tang X; Hu D; Li G; Song G
Front Public Health; 2022; 10():1026751. PubMed ID: 36589938
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-30 modulates metabolic inflammation by regulating Notch signaling in adipose tissue macrophages.
Miranda K; Yang X; Bam M; Murphy EA; Nagarkatti PS; Nagarkatti M
Int J Obes (Lond); 2018 Jun; 42(6):1140-1150. PubMed ID: 29899524
[TBL] [Abstract][Full Text] [Related]
14. Differences in vitamin D concentration between metabolically healthy and unhealthy obese adults: associations with inflammatory and cardiometabolic markers in 4391 subjects.
Esteghamati A; Aryan Z; Esteghamati A; Nakhjavani M
Diabetes Metab; 2014 Nov; 40(5):347-55. PubMed ID: 24811744
[TBL] [Abstract][Full Text] [Related]
15. Biochemical predictors of metabolically unhealthy obesity in children and adolescents.
Cho AY; Roh JG; Shim YS; Lee HS; Hwang JS
J Pediatr Endocrinol Metab; 2022 Jan; 35(1):97-103. PubMed ID: 34802201
[TBL] [Abstract][Full Text] [Related]
16. A distinct fatty acid profile underlies the reduced inflammatory state of metabolically healthy obese individuals.
Perreault M; Zulyniak MA; Badoud F; Stephenson S; Badawi A; Buchholz A; Mutch DM
PLoS One; 2014; 9(2):e88539. PubMed ID: 24520395
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Risk Factors Associated With the Metabolically Healthy Obese (MHO) Phenotype Compared to the Metabolically Unhealthy Obese (MUO) Phenotype in Children.
Genovesi S; Antolini L; Orlando A; Gilardini L; Bertoli S; Giussani M; Invitti C; Nava E; Battaglino MG; Leone A; Valsecchi MG; Parati G
Front Endocrinol (Lausanne); 2020; 11():27. PubMed ID: 32117055
[No Abstract] [Full Text] [Related]
18. Metabolomics Reveals Metabolically Healthy and Unhealthy Obese Individuals Differ in their Response to a Caloric Challenge.
Badoud F; Lam KP; Perreault M; Zulyniak MA; Britz-McKibbin P; Mutch DM
PLoS One; 2015; 10(8):e0134613. PubMed ID: 26274804
[TBL] [Abstract][Full Text] [Related]
19. Adipose Tissue Macrophage Polarization in Healthy and Unhealthy Obesity.
Ruggiero AD; Key CC; Kavanagh K
Front Nutr; 2021; 8():625331. PubMed ID: 33681276
[TBL] [Abstract][Full Text] [Related]
20. Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue.
Esser N; L'homme L; De Roover A; Kohnen L; Scheen AJ; Moutschen M; Piette J; Legrand-Poels S; Paquot N
Diabetologia; 2013 Nov; 56(11):2487-97. PubMed ID: 24013717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
